#	Pagina
attuale pagina	/open-h2020/projects/226601/index.html

Opendata, web and dolomites

Savesight SIGNED

Contact lens embedded sensor for ocular hypertension and glaucoma monitoring

Total Cost €

EC-Contrib. €

Partnership

Views

Savesight project word cloud

Explore the words cloud of the Savesight project. It provides you a very rough idea of what is the project "Savesight" about.

glaucoma patient sensor edge stealthy 2022 recognised view hypertension reduces diagnose 111 worldwide caused intraocular burden continuous progression steadily electrical proprietary chronic revenues professionals fraction form rely conventional competitor mainly 24 million people 294 comfort prominent glakolens hour scientific direct full cure 2021 12 significantly aid diurnal reliability mechanical issue gt healthcare blindness accuracy pressure heavy patients safety technologies patents 2026 elevated create grow competitors market algorithms treatment international monitoring cycle indirect quality billion sufficient plans report pending superior ocular lens monitorization invasive single iop contact cutting clinic permanent angle equal granted 2040 enter medical life marketscope accurately monitor overcome

Project "Savesight" data sheet

The following table provides information about the project.

Coordinator	GLAKOLENS BIYOMEDIKAL BIYOTEKNOLOJISANAYI VE TICARET ANONIM SIRKETI Organization address address: BOGAZICI UNIVERSITY, KUZEY KAMPUS, TEKNOPARK 306, BEBEK YOLU SOKAK 2/5, RUMELI HISARI MAHALLESI city: SARIYER, ISTANBUL postcode: 34470 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Turkey [TR]
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
Code Call	H2020-SMEInst-2018-2020-1
Funding Scheme	SME-1
Starting year	2020
Duration (year-month-day)	from 2020-01-01 to 2020-06-30

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	GLAKOLENS BIYOMEDIKAL BIYOTEKNOLOJISANAYI VE TICARET ANONIM SIRKETI GLAKOLENS BIYOMEDIKAL BIYOTEKNOLOJISANAYI VE TICARET ANONIM SIRKETI Organization address address: BOGAZICI UNIVERSITY, KUZEY KAMPUS, TEKNOPARK 306, BEBEK YOLU SOKAK 2/5, RUMELI HISARI MAHALLESI city: SARIYER, ISTANBUL postcode: 34470 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	TR (SARIYER, ISTANBUL)	coordinator	50˙000.00

Map

Project objective

Glaucoma affects over 70 million people worldwide (>12 million in Europe), and this number is expected to grow steadily to reach 111 million by 2040. Glaucoma is a chronic condition with no permanent cure and is the second leading cause of blindness. It significantly reduces the quality of life and presents a heavy burden on healthcare systems. Its most prominent and stealthy form, namely open-angle glaucoma, is mainly caused by chronic ocular hypertension (high intraocular pressure [IOP]). Conventional methods used to diagnose elevated IOP, monitor the progression of glaucoma and create treatment algorithms rely on a single IOP measurement conducted at the clinic. Due to the diurnal cycle of IOP, conventional methods do not provide sufficient and reliable information to evaluate the condition of the patients accurately. GlakoLens has been developing a non-invasive contact lens embedded sensor system that will aid medical professionals to overcome this issue by continuous 24-hour monitorization of the IOP changes. GlakoLens' proprietary technology (1 granted and 3 pending international patents) based on years of cutting-edge scientific research enables superior features for the patient (better comfort, electrical and mechanical safety, and full field-of-view) at a fraction of the cost of the only direct competitor in the market while providing better measurement accuracy and reliability. Four more indirect competitors have recognised the need in the market and are developing products using different technologies to address this need. According to a report by Marketscope, IOP monitoring market is expected to reach €1.5 billion by 2021. Glakolens plans to enter the market by the end of 2022, with estimated revenues equal to about €294.6 million in 2026.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SAVESIGHT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SAVESIGHT" are provided by the European Opendata Portal: CORDIS opendata.